Moreover, considering its strong inflammatory effects, visfatin has provided reliable evidence regarding prediction of the prevalence of cardiovascular diseases [8–10], and the findings of previous studies have suggested that acute coronary syndromes increase the incidence of VA [11, 12]. This evidence concerns the gene NAMPT and cardiovascular disorder.